NFKB1 and Alzheimer disease: Activation of NF-κB signaling is associated with subsequent activation of NLRP3 (Nod-like receptor pyrin domain containing 3), which is a critical regulator for inflammasome that controls the release of pro-inflammatory cytokines including IL-1β in AD [53, 54].